Optimising RWE to deliver value in healthcare

  • 23 September 2026
  • 09:00 - 14:00 CEST
  • VBO FEB - Verbond van Belgische Ondernemingen
    Fédération des Entreprises de Belgique
  • 23 September 2026
  • 09:00 - 14:00 CEST
  • VBO FEB - Verbond van Belgische Ondernemingen
    Fédération des Entreprises de Belgique
Register here
  • 09:00-09:30

Participant arrival and registration

Welcome and opening statement

  • 09:30-09:35

Welcome and housekeeping

Karen Facey, RWE4Decisions Facilitator

Opening session: Navigating Europe’s HTA Future; Policy Implementation and Global Pressures

Moderated by

Karen Facey, RWE4Decisions Facilitator

François Meyer, RWE4Decisions Facilitator

  • 09:35-09:50

Keynote address: Irish Presidency of the Council of the EU – State of the Nation on the Implementation of the HTA Regulation, with a focus on JCAs and JSCs

Roisin Adams, Head of HTA Strategy National Centre for Pharmaeconomics, Ireland

  • 09:50-10:10

Multistakeholder panel: The geopolitical shifts impacting HTA/Payers in the EU

Roisin Adams, Head of HTA Strategy National Centre for Pharmaeconomics, Ireland

  • 10:10-10:30

Moderated Q&A with the audience, including keynote speaker

Roisin Adams, Head of HTA Strategy National Centre for Pharmaeconomics, Ireland

Multistakeholder panel discussion: The European Health Data Space – Readiness, Challenges, and the Road to Implementation

Moderated by

Eric Sutherland, OECD

  • 10:30-10:40

Keynote: Status of the EHDS Implementation, Implementing Acts, TEHDAS Work

TEHDAS representative

  • 10:40-10:55

Initial reflections: A multistakeholder view of the key opportunities and challenges in EHDS implementation

Roisin Adams, Head of HTA Strategy National Centre for Pharmaeconomics, Ireland

  • 10:55-11:10

Moderated Q&A with the audience

Roisin Adams, Head of HTA Strategy National Centre for Pharmaeconomics, Ireland

  • 11:10-11:40

Break

Multistakeholder panel discussion: Policy and methodology for AI in RWD Collection

Moderated by

Niklas Hedberg, TLV

  • 11:40-11:50

Keynote: The EMA/FDA 10 principles for AI to generate decision-grade RWD

TEHDAS representative

  • 11:50-12:10

Initial reflections: How to ensure that AI-generated RWD meets HTA, patient, and societal needs?

Roisin Adams, Head of HTA Strategy National Centre for Pharmaeconomics, Ireland

  • 12:10-12:25

Moderated Q&A with the audience

Roisin Adams, Head of HTA Strategy National Centre for Pharmaeconomics, Ireland

Closing session: Patient-relevant RWE; key learnings and next steps for RWE4Decisions

Moderated by

Karen Facey, RWE4Decisions Facilitator

  • 12:25-12:35

Review of RWE4Decisions Activities in 2026

Karen Facey, RWE4Decisions Facilitator

  • 12:35-12:55

Next steps for RWE4Decisions: Steering Group discussion

Roisin Adams, Head of HTA Strategy National Centre for Pharmaeconomics, Ireland

  • 12:55-13:00

Wrap-up and next steps

Roisin Adams, Head of HTA Strategy National Centre for Pharmaeconomics, Ireland

  • 13:00 – 14:00

Networking lunch